{
    "SPADE_N_04785": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2003/0144184 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2003_0144184_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2003-7-31",
                "Family Info": "EP1513544A2,EP1513544A4,EP1513544B1,US6713078,WO2004033479A2,WO2004033479A3",
                "Patent Title": "Retrocyclins: antiviral and antimicrobial peptides.",
                "Abstract": "Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens."
            },
            {
                "Patent No": "US 2009/0264344 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2009_0264344_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2009-10-22",
                "Family Info": "US7314858,US7718610,US20050272645,WO2006052637A1",
                "Patent Title": "Retrocyclins, antiviral and antimicrobial peptides.",
                "Abstract": "Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV1 retrovirus or other sexuallytransmitted pathogens."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_04785",
            "Sequence": "MRIIALLAAILLVALQVRAGPLQARGDEAPGQEQRGPEDQDISISFAWDKSSALQVSGSTRGMVCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRVD",
            "Sequence Length": 97,
            "Peptide Name": "Sequence 13 from Patent US 20030144184",
            "Source": "Homo sapiens",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Antiviral"
            ],
            "Frequent Amino Acids": "LRA",
            "Absent Amino Acids": "HOU",
            "Basic Residues": 11,
            "Acidic Residues": 9,
            "Hydrophobic Residues": 43,
            "Polar Residues": 54,
            "Positive Residues": 11,
            "Negative Residues": 9,
            "Mass": 10504.08,
            "PI": 8.3,
            "Net Charge": 2,
            "Hydrophobicity": 0.18,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02298",
                    "Similarity": 1.0,
                    "Sequence": "VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRVD"
                },
                {
                    "SPADE_ID": "SPADE_N_03151",
                    "Similarity": 1.0,
                    "Sequence": "VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV"
                },
                {
                    "SPADE_ID": "SPADE_N_02284",
                    "Similarity": 0.5402298850574713,
                    "Sequence": "MRTFALLTAVLLVALQAQAGPLQARCDEAAGQEQPGVDDQDISISFAWDKISALQASGERGQYEEPQSLQGWMGDRLWNRVSMVHVT"
                }
            ]
        }
    }
}